This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is e.l.f. Beauty (ELF) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.
HELE or ELF: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. ELF: Which Stock Is the Better Value Option?
Prestige Consumer (PBH) Looks Well-Placed on Brand Strength
by Zacks Equity Research
Prestige Consumer (PBH) benefits from its solid brand portfolio and favorable demand. E-commerce growth has also been an upside.
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYC
Has e.l.f. Beauty (ELF) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how e.l.f. Beauty (ELF) and Helen of Troy (HELE) have performed compared to their sector so far this year.
e.l.f. Beauty's (ELF) Naturium Buyout to Boost Skincare Lineup
by Zacks Equity Research
e.l.f. Beauty's (ELF) recent announcement of its $355 million acquisition of Naturium signals a strategic move that can substantially boost its presence in the skincare market.
Brokers Suggest Investing in e.l.f. Beauty (ELF): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HELE vs. ELF: Which Stock Is the Better Value Option?
by Zacks Equity Research
HELE vs. ELF: Which Stock Is the Better Value Option?
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
e.l.f. Beauty (ELF) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.
International Flavors (IFF) Announces Creative Center Completion
by Zacks Equity Research
International Flavors (IFF) opens a facility in New Century to expand its innovation footprint.
Are Consumer Staples Stocks Lagging Celsius (CELH) This Year?
by Zacks Equity Research
Here is how Celsius Holdings Inc. (CELH) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
4 Consumer Staples Stocks You Can Bank on for the Months Ahead
by Abhinab Dasgupta
e.l.f. Beauty (ELF), Molson Coors (TAP), J&J Snack (JJSF) and Boston Beer (SAM) are four stocks that you can look into as rate hikes come to a close.
Seeking Growth? Buy These 3 Top-Ranked Mid-Caps
by Derek Lewis
Mid-cap stocks can fly under the radar despite commonly offering a nice blend of growth potential and stability. And for those seeking exposure, these three have seen their outlooks shift positively.
5 Reasons US Equity Markets Will Digest Gains Further
by Andrew Rocco
Few investors likely predicted the strong stock markets returns of 2023. Strategist Andrew Rocco lays out 5 reasons why equities may finally need to rest and lets you know what you should do in the interim.
Bear of the Day: The Estee Lauder Companies Inc. (EL)
by Andrew Rocco
Currency headwinds, growing competition, and slowing growth point to a bleak outlook for Estee Lauder shares.
Time to Buy These Top-Rated Stocks After Massive Earnings Beats
by Shaun Pruitt
The earnings potential of these companies is very appealing and easily surpassing their quarterly bottom-line expectations reconfirmed this.
Nu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings Beat
by Zacks Equity Research
Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.
E.l.f. Beauty (ELF) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 89.66% and 16.99%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
This Week's Must-See Earnings Charts
by Tracey Ryniec
Don't let all the earnings reports confuse you. Focus on these 5 companies.
Factors Likely to Influence AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) Q2 results are expected to reflect the benefits of its unique commercial strategy, a strong brand portfolio, and investments in brands and operation excellence.
Here's What Awaits Clorox (CLX) When It Reports Q4 Earnings
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from solid demand trends, pricing actions, digital investments, cost-saving efforts and the IGNITE strategy.
Factors Likely to Influence Diageo's (DEO) FY23 Earnings
by Zacks Equity Research
Diageo's (DEO) fiscal 2023 results are expected to reflect gains from its effective marketing, strong commercial execution and favorable industry trends of premiumization.
E.l.f. Beauty (ELF) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $113.07, marking a -0.9% move from the previous day.
E.l.f. Beauty (ELF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
E.l.f. Beauty (ELF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.